ClinicalTrialsFinder

Post-essential Thrombocythemia Myelofibrosis(Post-ET MF) Clinical Trials in Sapporo, Hokkaido

1 recruitingSapporo, Hokkaido, Japan

Showing 1–1 of 1 trials

Recruiting
Phase 1

Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis

Primary myelofibrosis (PMF)Post-polycythemia Vera Myelofibrosis (Post-PV MF)Post-essential Thrombocythemia Myelofibrosis(Post-ET MF)
Novartis Pharmaceuticals6 enrolled6 locationsNCT07340138